• +91 882 525 4416
  • bd@essentialmarketinsights.com
  • Pune, MH, India

Global Monoclonal Antibody Market

Monoclonal antibodies (mAb or moAb) are laboratory-produced proteins or identical immunoglobulins that act like human antibodies in the immune system. The mAbs can mimic the immune system during the attack on cancer cells. These antibodies are specifically designed to link specific antigens that are more numerous on the surface of the cancer cells rather than healthy cells because of the capability of making copies in the lab.

Global Oligonucleotide Synthesis Market

Oligonucleotide synthesis is the chemical synthesis of nucleic acids with a specified chemical sequence in various sizes. The method is used for several applications under the life science research and medicine research. Earlier, the companies followed the typical traditional way of oligonucleotide synthesis, carried out manually on solid or in the liquid phase supported by glass columns, kitted with porous filters.

Global Peptide and Anticoagulant Drugs Market

Peptides play a primary agent in any biological mechanism, which has been developed to treat human diseases. Peptides are regulatory molecules that act like natural hormones. Earlier, peptides were used in balancing metabolic diseases, but, recently, owing to the growing advancements, peptides can be modified chemically to achieve complicated tasks and different therapeutic applications such as cancer.

Global Recombinant Proteins Market

Recombinant protein is an engineered form of a natural protein, produced in several approaches to modifying gene sequences, increasing the production of proteins, and manufacturing useful commercial products. Recombinant proteins are generally used to produce antibodies & enzymes for disease treatment, pharmaceutical products, protein-based polymers for drug delivery, protein scaffolds for tissue engineering, and among others.